Evidence map›Paper›PMID 34945823›Full record

ArticleJournal of personalized medicine2021

Brain Linac-Based Radiation Therapy: "Test Drive" of New Immobilization Solution and Surface Guided Radiation Therapy.

Fabiana Gregucci, Ilaria Bonaparte, Alessia Surgo, Morena Caliandro, Roberta Carbonara, Maria Paola Ciliberti, Alberto Aga, Francesco Berloco, Marina De Masi, Christian De Pascali and 9 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Are conventional and hypofractionated chemoradiotherapy comparable in glioblastoma patients?Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastoma.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Fabiana GregucciDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.ORCID 0000-0002-9947-9650
Ilaria BonaparteDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Alessia SurgoDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.ORCID 0000-0003-4502-9635
Morena CaliandroDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Roberta CarbonaraDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Maria Paola CilibertiDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Alberto AgaDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Francesco BerlocoDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Marina De MasiDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Christian De PascaliDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Federica FragnoliDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Chiara IndellicatiDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Rosalinda ParabitaDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Giuseppe SanfrancescoDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Luciana BranàDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Annarita CiociaDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Domenico CurciDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Pietro GuidaDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.
Alba FiorentinoDepartment of Radiation Oncology, Miulli General Regional Hospital, 70021 Acquaviva delle Fonti-Bari, Italy.ORCID 0000-0003-4201-5852
Ospedale Generale Regionale Francesco Miulli · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo test inter-fraction reproducibility, intrafraction stability, technician aspects, and patient/physician's comfort of a dedicated immobilization solution for Brain Linac-based radiation therapy (RT).

methodsA pitch-enabled head positioner with an open-face mask were used and, to evaluate inter- and intrafraction variations, 1-3 Cone-Beam Computed Tomography (CBCT) were performed. Surface Guided Radiation Therapy (SGRT) was used to evaluate intrafraction variations at 3 time points: initial (i), final (f), and monitoring (m) (before, end, and during RT). Data regarding technician mask aspect were collected.

resultsBetween October 2019 and April 2020, 69 patients with brain disease were treated: 45 received stereotactic RT and 24 conventional RT; 556 treatment sessions and 863 CBCT's were performed. Inter-fraction CBCT mean values were longitudinally 0.9 mm, laterally 0.8 mm, vertically 1.1 mm, roll 0.58°, pitch 0.59°, yaw 0.67°. Intrafraction CBCT mean values were longitudinally 0.3 mm, laterally 0.3 mm, vertically 0.4 mm, roll 0.22°, pitch 0.33°, yaw 0.24°. SGRT intrafraction mean values were: i_, m_, f_ longitudinally 0.09 mm, 0.45 mm, 0.31 mm; i_, m_, f_ laterally 0.07 mm, 0.36 mm, 0.20 mm; i_, m_, f_ vertically 0.06 mm, 0.31 mm, 0.22 mm; i_, m_, f_ roll 0.025°, 0.208°, 0.118°; i_, m_, f_ pitch 0.036°, 0.307°, 0.194°; i_, m_, f_ yaw 0.039°, 0.274°, 0.189°.

conclusionsThis immobilization solution is reproducible and stable. Combining CBCT and SGRT data confirm that 1 mm CTV-PTV margin for Linac-based SRT was adequate. Using open-face mask and SGRT, for conventional RT, radiological imaging could be omitted.

Indexed as

brainlinear accelerator-based radiotherapyradiosurgerysurface guided radiation therapy

Identifiers

PMID34945823
PMCPMC8709255
OpenAlexW4200449973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.